These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 28952434)

  • 1. Blood-Vessel-on-a-Chip Platforms for Evaluating Nanoparticle Drug Delivery Systems.
    Li Y; Zhu K; Liu X; Zhang YS
    Curr Drug Metab; 2018; 19(2):100-109. PubMed ID: 28952434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microfluidics in nanoparticle drug delivery; From synthesis to pre-clinical screening.
    Ahn J; Ko J; Lee S; Yu J; Kim Y; Jeon NL
    Adv Drug Deliv Rev; 2018 Mar; 128():29-53. PubMed ID: 29626551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microfluidic Devices: A Tool for Nanoparticle Synthesis and Performance Evaluation.
    Gimondi S; Ferreira H; Reis RL; Neves NM
    ACS Nano; 2023 Aug; 17(15):14205-14228. PubMed ID: 37498731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current developments and applications of microfluidic technology toward clinical translation of nanomedicines.
    Liu D; Zhang H; Fontana F; Hirvonen JT; Santos HA
    Adv Drug Deliv Rev; 2018 Mar; 128():54-83. PubMed ID: 28801093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microfluidic technologies for vasculature biomimicry.
    Hu C; Chen Y; Tan MJA; Ren K; Wu H
    Analyst; 2019 Jul; 144(15):4461-4471. PubMed ID: 31162494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances of Microfluidic Platforms for Controlled Drug Delivery in Nanomedicine.
    Ejeta F
    Drug Des Devel Ther; 2021; 15():3881-3891. PubMed ID: 34531650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organ-on-a-chip platforms for accelerating the evaluation of nanomedicine.
    Chen X; Zhang YS; Zhang X; Liu C
    Bioact Mater; 2021 Apr; 6(4):1012-1027. PubMed ID: 33102943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organ-on-a-chip platforms for studying drug delivery systems.
    Bhise NS; Ribas J; Manoharan V; Zhang YS; Polini A; Massa S; Dokmeci MR; Khademhosseini A
    J Control Release; 2014 Sep; 190():82-93. PubMed ID: 24818770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microengineered Organ-on-a-chip Platforms towards Personalized Medicine.
    Kankala RK; Wang SB; Chen AZ
    Curr Pharm Des; 2018; 24(45):5354-5366. PubMed ID: 30799783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microfluidic and lab-on-a-chip preparation routes for organic nanoparticles and vesicular systems for nanomedicine applications.
    Capretto L; Carugo D; Mazzitelli S; Nastruzzi C; Zhang X
    Adv Drug Deliv Rev; 2013 Nov; 65(11-12):1496-532. PubMed ID: 23933616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microfluidic technologies for accelerating the clinical translation of nanoparticles.
    Valencia PM; Farokhzad OC; Karnik R; Langer R
    Nat Nanotechnol; 2012 Oct; 7(10):623-9. PubMed ID: 23042546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microfluidic-Based Platform for the Evaluation of Nanomaterial-Mediated Drug Delivery: From High-Throughput Screening to Dynamic Monitoring.
    Yang Y; Liu S; Geng J
    Curr Pharm Des; 2019; 25(27):2953-2968. PubMed ID: 31362686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro models and systems for evaluating the dynamics of drug delivery to the healthy and diseased brain.
    Modarres HP; Janmaleki M; Novin M; Saliba J; El-Hajj F; RezayatiCharan M; Seyfoori A; Sadabadi H; Vandal M; Nguyen MD; Hasan A; Sanati-Nezhad A
    J Control Release; 2018 Mar; 273():108-130. PubMed ID: 29378233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomimetic microfluidic device for in vitro antihypertensive drug evaluation.
    Li L; Lv X; Ostrovidov S; Shi X; Zhang N; Liu J
    Mol Pharm; 2014 Jul; 11(7):2009-15. PubMed ID: 24673554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organ-on-a-Chip Systems: Microengineering to Biomimic Living Systems.
    Zheng F; Fu F; Cheng Y; Wang C; Zhao Y; Gu Z
    Small; 2016 May; 12(17):2253-82. PubMed ID: 26901595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial cell mechanosensing: New insights gained from biomimetic microfluidic models.
    Gray KM; Stroka KM
    Semin Cell Dev Biol; 2017 Nov; 71():106-117. PubMed ID: 28633977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential of biomimetic nanoparticles for tumor-targeted drug delivery.
    Li B; Wang F; Gui L; He Q; Yao Y; Chen H
    Nanomedicine (Lond); 2018 Aug; 13(16):2099-2118. PubMed ID: 30226404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal tumor-on-a-chip system: A 3D tool for precision onco-nanomedicine.
    Carvalho MR; Barata D; Teixeira LM; Giselbrecht S; Reis RL; Oliveira JM; Truckenmüller R; Habibovic P
    Sci Adv; 2019 May; 5(5):eaaw1317. PubMed ID: 31131324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organ-on-a-Chip: A Preclinical Microfluidic Platform for the Progress of Nanomedicine.
    Rodrigues RO; Sousa PC; Gaspar J; Bañobre-López M; Lima R; Minas G
    Small; 2020 Dec; 16(51):e2003517. PubMed ID: 33236819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures.
    Ragelle H; Danhier F; Préat V; Langer R; Anderson DG
    Expert Opin Drug Deliv; 2017 Jul; 14(7):851-864. PubMed ID: 27730820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.